falsefalse

Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia - Episode 1

Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL

,

Amanda Przespolewski, DO, and Ibrahim Aldoss, MD define and discuss how to diagnose patients with Ph+ALL.

Current Time 0:00
Duration 4:14
Loaded: 0%
Stream Type LIVE
Remaining Time 4:14
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
Now Viewing
EP. 1: Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL
EP. 2: Evolving Standard of Care for Patients Diagnosed with Ph+ ALL
EP. 3: Recent Updates from the PhALLCON Study
EP. 4: Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL
EP. 5: Notable Advancements in Treatment for ALL
EP. 6: Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL

Related Content:

Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic LeukemiaOncLive News Network®
Perioperative Nivolumab in Resectable NSCLC: Updated Data From CheckMate-77T
How Immunotherapy Is Affecting Perioperative Treatment Decisions in Early-Stage NSCLC
Relacorilant Plus Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer: The ROSELLA Trial
x